Healthcare provider profile · identity verified

Miguel E Rodriguez, MD

Internal Medicine · LOS ANGELES, CA · NPI 1972600880

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metformin Hcl	Metformin Hcl	381	122
Levothyroxine Sodium	Levothyroxine Sodium	376	105
Atorvastatin Calcium	Atorvastatin Calcium	341	100
Trulicity	Dulaglutide	286	58
Amlodipine Besylate	Amlodipine Besylate	240	83
Famotidine	Famotidine	229	88
Glipizide Er	Glipizide	181	56
Gabapentin	Gabapentin	143	65
Ozempic	Semaglutide	137	34
Januvia	Sitagliptin Phosphate	131	33
Buspirone Hcl	Buspirone Hcl	126	55
Losartan Potassium	Losartan Potassium	117	34
Albuterol Sulfate Hfa	Albuterol Sulfate	114	43
Jardiance	Empagliflozin	111	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	109	32
Lisinopril	Lisinopril	108	37
Metoprolol Succinate	Metoprolol Succinate	106	37
Benazepril Hcl	Benazepril Hcl	93	35
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	89	33
Azithromycin	Azithromycin	83	59
Carvedilol	Carvedilol	81	19
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	78	15
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	77	suppressed
Diclofenac Sodium	Diclofenac Sodium	76	37
Rosuvastatin Calcium	Rosuvastatin Calcium	76	24
Fluticasone Propionate	Fluticasone Propionate	75	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	72	22
Tramadol Hcl	Tramadol Hcl	70	11
Hydralazine Hcl	Hydralazine Hcl	68	19
Montelukast Sodium	Montelukast Sodium	68	23
Tresiba Flextouch U-200	Insulin Degludec	68	21
Simvastatin	Simvastatin	67	22
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	66	17
Rybelsus	Semaglutide	63	23
Fluoxetine Hcl	Fluoxetine Hcl	61	21
Farxiga	Dapagliflozin Propanediol	60	19
Repaglinide	Repaglinide	60	18
Meloxicam	Meloxicam	55	29
Tamsulosin Hcl	Tamsulosin Hcl	55	17
Cinacalcet Hcl	Cinacalcet Hcl	54	22
Furosemide	Furosemide	54	18
Levemir Flexpen	Insulin Detemir	54	20
Pantoprazole Sodium	Pantoprazole Sodium	52	11
Glipizide	Glipizide	49	18
Clonazepam	Clonazepam	48	12
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	45	17
Donepezil Hcl	Donepezil Hcl	44	suppressed
Fenofibrate	Fenofibrate,micronized	44	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	32
Lantus	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Alendronate Sodium	Alendronate Sodium	42	17
Potassium Chloride	Potassium Chloride	40	11
Glimepiride	Glimepiride	39	12
Hydrocortisone	Hydrocortisone	39	17
Indapamide	Indapamide	38	13
Valsartan	Valsartan	38	14
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Meclizine Hcl	Meclizine Hcl	35	22
Fluconazole	Fluconazole	34	23
Trazodone Hcl	Trazodone Hcl	34	11
Hydrochlorothiazide	Hydrochlorothiazide	33	11
Methimazole	Methimazole	33	11
Baclofen	Baclofen	32	23
Comfort Ez Pen Needle	Pen Needle, Diabetic	32	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	32	suppressed
Irbesartan	Irbesartan	32	12
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	32	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	31	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	26	suppressed
Eliquis	Apixaban	25	suppressed
Mirtazapine	Mirtazapine	25	17
Ondansetron Hcl	Ondansetron Hcl	25	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Nifedipine Er	Nifedipine	24	suppressed
Omeprazole	Omeprazole	24	suppressed
Promethazine-Dm	Promethazine/Dextromethorphan	24	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	23	suppressed
Cabergoline	Cabergoline	23	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	23	13
Synthroid	Levothyroxine Sodium	23	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Lactulose	Lactulose	22	18
Lorazepam	Lorazepam	22	suppressed
Temazepam	Temazepam	22	suppressed
Acarbose	Acarbose	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Ssd	Silver Sulfadiazine	20	16
Sucralfate	Sucralfate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	11
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Amoxicillin	Amoxicillin	18	13
Erythromycin	Erythromycin Base	18	11
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Ciclopirox	Ciclopirox Olamine	17	13
Memantine Hcl	Memantine Hcl	17	suppressed
Metronidazole	Metronidazole	17	13
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	16	13
Chlorthalidone	Chlorthalidone	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	15	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Procto-Med Hc	Hydrocortisone	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Naproxen	Naproxen	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Estradiol	Estradiol	12	11
Fenofibrate	Fenofibrate	12	suppressed
Invokana	Canagliflozin	12	suppressed
Levemir	Insulin Detemir	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Allopurinol	Allopurinol	11	suppressed
Keppra	Levetiracetam	11	suppressed
Tegretol	Carbamazepine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error